AAAAAA
Results:
1-17
|
Results: 17
Authors:
SECHAUD R
BATTLE MM
SAMBOL NC
Citation: R. Sechaud et al., POPULATION PHARMACODYNAMICS OF TASOSARTAN, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 81-81
Authors:
SAMBOL NC
BATTLE MM
Citation: Nc. Sambol et Mm. Battle, POPULATION PHARMACOKINETICS (PK) OF ENOLTASOSARTAN, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 84-84
Authors:
KASTRISSIOS H
KATZ SD
GROSSBARD EB
ALLGREN RL
SAMBOL NC
Citation: H. Kastrissios et al., PHARMACOKINETICS AND PHARMACODYNAMICS (PK PD) OF HUMAN BRAIN NATRIURETIC PEPTIDE (HBNP) IN PATIENTS WITH CONGESTIVE-HEART-FAILURE (CHF)/, Clinical pharmacology and therapeutics, 61(2), 1997, pp. 47-47
Authors:
LIU FY
SAMBOL NC
GIANNINI RP
LIU CY
Citation: Fy. Liu et al., IN-VITRO IN-VIVO RELATIONSHIP OF ORAL EXTENDED-RELEASE DOSAGE FORMS, Pharmaceutical research, 13(10), 1996, pp. 1501-1506
Authors:
SAMBOL NC
BROOKES LG
CHIANG J
GOODMAN AM
LIN ET
LIU CY
BENET LZ
Citation: Nc. Sambol et al., FOOD-INTAKE AND DOSAGE LEVEL, BUT NOT TABLET VS SOLUTION DOSAGE FORM,AFFECT THE ABSORPTION OF METFORMIN HCL IN MAN, British journal of clinical pharmacology, 42(4), 1996, pp. 510-512
Authors:
SAMBOL NC
CHIANG J
OCONNER M
LIU CY
LIN ET
GOODMAN AM
BENET LZ
KARAM JH
Citation: Nc. Sambol et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF METFORMIN IN HEALTHY-SUBJECTS AND PATIENTS WITH NONINSULIN-DEPENDENT DIABETES-MELLITUS, Journal of clinical pharmacology, 36(11), 1996, pp. 1012-1021
Authors:
SAMBOL NC
TCHENG JE
KITT M
LORENZ T
Citation: Nc. Sambol et al., POPULATION PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF INTEGRELIN, A PLATELET-AGGREGATION INHIBITOR, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 84-84
Authors:
ZHENG J
SAMBOL NC
ZIMMERMAN J
ZAIDI A
Citation: J. Zheng et al., POPULATION PHARMACOKINETICS (PK) OF SIROLIMUS, Clinical pharmacology and therapeutics, 59(2), 1996, pp. 85-85
Authors:
LIU FY
SAMBOL NC
GIANNINI RP
LIU CY
Citation: Fy. Liu et al., PHARMACOKINETICS OF ORAL EXTENDED-RELEASE DOSAGE FORMS .1. RELEASE KINETICS, CONCENTRATION, AND ABSORBED FRACTION, Pharmaceutical research, 12(5), 1995, pp. 720-728
Authors:
LIU CY
SAMBOL NC
Citation: Cy. Liu et Nc. Sambol, PHARMACODYNAMIC ANALYSIS OF ANALGESIC CLINICAL-TRIALS USING EMPIRICAL-METHODS, Pharmaceutical research, 12(3), 1995, pp. 438-445
Authors:
SAMBOL NC
CHIANG J
LIN ET
GOODMAN AM
LIU CY
BENET LZ
COGAN MG
Citation: Nc. Sambol et al., KIDNEY-FUNCTION AND AGE ARE BOTH PREDICTORS OF PHARMACOKINETICS OF METFORMIN, Journal of clinical pharmacology, 35(11), 1995, pp. 1094-1102
Authors:
WADE JR
SAMBOL NC
Citation: Jr. Wade et Nc. Sambol, FELODIPINE POPULATION DOSE-RESPONSE AND CONCENTRATION-RESPONSE RELATIONSHIPS IN PATIENTS WITH ESSENTIAL-HYPERTENSION, Clinical pharmacology and therapeutics, 57(5), 1995, pp. 569-581
Authors:
SAMBOL NC
LIU CY
COOPER SA
SHEINER LB
GREENE JJ
LIN ET
Citation: Nc. Sambol et al., POPULATION PHARMACOKINETICS (PK) AND PHARMACODYNAMICS (PD) OF LOW-DOSE KETOPROFEN IN PATIENTS WITH DENTAL PAIN, Clinical pharmacology and therapeutics, 57(2), 1995, pp. 165-165
Authors:
MASH DC
DOUYON R
HEARN WL
SAMBOL NC
SANCHEZRAMOS J
Citation: Dc. Mash et al., A PRELIMINARY-REPORT ON THE SAFETY AND PHARMACOKINETICS OF IBOGAINE, Biological psychiatry, 37(9), 1995, pp. 652-652
Authors:
WADE JR
BEAL SL
SAMBOL NC
Citation: Jr. Wade et al., INTERACTION BETWEEN STRUCTURAL, STATISTICAL, AND COVARIATE MODELS IN POPULATION PHARMACOKINETIC ANALYSIS, Journal of pharmacokinetics and biopharmaceutics, 22(2), 1994, pp. 165-177
Authors:
WADE JR
BEAL SL
SAMBOL NC
Citation: Jr. Wade et al., INTERACTION BETWEEN STRUCTURAL, STATISTICAL AND COVARIATE MODELS IN POPULATION PHARMACOKINETICS ANALYSIS, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 163-163
Authors:
SAMBOL NC
HILL J
Citation: Nc. Sambol et J. Hill, PHARMACOKINETICS (PK) OF HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) IN PATIENTS WITH NEUTROPENIA USING A MIXED EFFECTS MODEL, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 199-199
Risultati:
1-17
|